Haptoglobin concentrations in dogs undergoing trilostane treatment for hyperadrenocorticism

Veterinary Clinical Pathology

Volumn 34, Issue 3, 2005, Pages 255-258

  McGrotty, Y L ^a,b   Arteaga, A ^a   Knottenbelt, C M ^a   Ramsey, I K ^a   Eckersall, P D ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b BROADLEYS VETERINARY HOSPITAL   (United Kingdom)

Author keywords

Acute phase protein; Dog; Haptoglobin; Hyperadrenocorticism; Trilostane

Indexed keywords

CANIS FAMILIARIS;

EID: 26244465711     PISSN: 02756382     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-165X.2005.tb00050.x     Document Type: Article

References (18)

1. Thompson D, Milford-Ward A, Whicher J. The value of acute phase measurements in clinical practice. Ann Clin Biochem. 1992;29:123-131.
2. Yamamoto S, Shida T, Miyaji S, et al. Changes in serum C-reactive protein levels in dogs with various disorders and surgical traumas. Vet Res Commun. 1993;17:85-93.
3. Eckersall PD, Conner JG. Bovine and canine acute phase proteins. Vet Res Commun. 1988;12:169-178.
4. Eckersall PD. Acute phase proteins as markers of inflammatory lesions. Comp Haematol Int. 1995;5:93-97.
5. McGrotty YL, Knottenbelt CM, Ramsey IK, Reid SWJ, Eckersall PD. Haptoglobin concentrations in a canine hospital population. Vet Rec. 2003;152:562-564.
6. Conner JG, Eckersall PD, Ferguson J, Douglas TA. The acute phase response in the dog following surgical trauma. Res Vet Sci. 1988;45:107-110.
7. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J. 1990;265:621-636.
8. Harvey JW, West CL. Prednisolone-induced increases in serum alpha-2-globulin and haptoglobin concentrations in dogs. Vet Pathol. 1987;24:90-92.
9. Potts GO, Creange JE, Hardong HR, Schane HP. Trilostane, an orally active inhibitor of steroid biosynthesis. Steroids. 1978;32:257-267.
10. Eckersall PD, Duthie S, Safi S, et al. An automated biochemical assay for haptoglobin: prevention of interference from albumin. Comp Haematol Int. 1999;9:117-124.
11. Fraser CG. Interpretation of Clinical Chemistry Laboratory Data. Edinburgh, UK: Blackwell Scientific; 1986:77-81.
12. Martinez-Subiela S, Tecles F, Eckersall PD, Ceron JJ. Serum concentrations of acute phase proteins in dogs with leishmaniasis. Vet Rec. 2002;150:241-244.
13. Martinez-Subiela S, Ginel PJ, Ceron JJ. Effects of different glucocoticoid treatments on serum acute phase proteins in dogs. Vet Rec. 2004;154:814-817.
14. Winterberg B, Vetter W, Groth H, Greninger P, Vetter H. Primary aldosteronism: treatment with trilostane. Cardiology. 1985;72 (suppl 1):117-121.
15. Ruckstuhl NS, Nett CS, Reusch CE. Results of clinical examinations, laboratory tests and ultrasonography in dogs with pituitary dependent hyperadrenocorticism treated with trilostane. Am J Vet Res. 2002;63:506-512.
16. Neiger R, Hurley K. 24 hour cortisol values in dogs with hyperadrenocorticism on trilostane [abstract]. In Proceedings of the 44th British Small Animal Veterinary Association. Birmingham, UK; April 5-8, 2001:549.
17. Ramsey IK, McGrotty YL. The effect of trilostane on ACTH stimulation tests performed at two different times post treatment [abstract]. In Proceedings of the 11th European Society of Veterinary Internal Medicine Conference. Dublin, Ireland; September 5-8, 2001:184-185.
18. Neiger R, Ramsey I, O'Connor J, Hurley KJ, Mooney CT. Trilostane treatment of 78 dogs with pituitary-dependent hyperadrenocorticism. Vet Rec. 2002;150:799-804.